作者: Samuel A. Yousem , Marina Nikiforova , Yuri Nikiforov
DOI: 10.1097/PAS.0B013E31816597CA
关键词: Adenocarcinoma 、 Epidermal growth factor receptor 、 Pathology 、 Cancer 、 Cancer research 、 Biology 、 Histopathology 、 V600E 、 Mutation 、 Lung cancer 、 KRAS
摘要: BRAF mutations in lung adenocarcinoma are much less common than the more frequently reported and mutually exclusive of KRAS EGFR genes, clinical histologic phenotype adenocarcinomas has not been described. We analyzed 222 lacking identified 10 with BRAF-V600E mutation. All were heterozygous. There was a slight female predilection (6:4) these elderly patients (average age 67 y) who found to have greater expected incidence intralobar satellite nodules N2 node involvement. The largely mixed type high papillary (80%) lepidic growth (50%). Adenocarcinomas this clinicopathologic may be worthwhile investigating for mutation as genetically oriented drug therapies emerge.